| No images? Click here Thursday, 24 February 2022 MEDIA ADVISORY WHO Recommendation on the Composition of Influenza Virus Vaccines for Use in the 2022-2023 Northern Hemisphere Influenza Season and the Global Influenza Surveillance and Response System (GISRS) WHAT: From 21-24 February 2022, WHO organized consultations with an advisory group of experts to analyse influenza virus surveillance data generated by the WHO Global Influenza Surveillance and Response System (GISRS), and issues recommendation on the composition of the influenza vaccines for the following influenza season. These recommendations are used by the national vaccine regulatory agencies and the pharmaceutical companies to develop, produce and license influenza vaccines. On 25 February 2022, the WHO Recommendation on the Composition of Influenza Virus Vaccines for Use in the 2022-2023 Northern Hemisphere Influenza Season will be announced publicly during an Information session in the morning. This will be followed by a Global Virtual Press Conference where the recommendation will be discussed. WHEN: · To follow the public part of the Information Session live on social media 10:00-11:30 CET (Geneva time) on Friday, 25 February 2022 Livestream: http://www.youtube.com/WHO · To join the Virtual Press Conference 13:00-14:15 / 1pm-2:15pm CET (Geneva time) on Friday, 25 February 2022 https://who-e.zoom.us/j/99674746732
Passcode: VPCfluVPC Phone:
International numbers available: https://who-e.zoom.us/u/acWjqSdcl6
Webinar ID: 996 7474 6732
Passcode for phone access: 801284321 Speakers · Dr Wenqing ZHANG, Head, Global Influenza Programme, WHO
· Dr Kanta SUBBARAO, Director, WHO Collaborating Centre for Reference and Research on Influenza, Victoria Infectious Diseases Reference Laboratory (VIDRL), Australia
· Dr David WENTWORTH, Director, WHO Collaborating Centre for the Surveillance, Epidemiology and Control of Influenza, Centers for Disease Control and Prevention (CDC), USA
· Dr John McCAULEY, Director, WHO Collaborating Centre for Reference and Research on Influenza, The Francis Crick Institute, UK NOTES FOR JOURNALISTS:
Please ensure you enter your name and media outlet (use name/outlet). Kindly note, only questions from media (one per journalist) are allowed. When you sign in you will be automatically put in the meeting room.
WHO reserves the right to remove any participant whose behaviour causes any disruption. The event is also broadcast on WHO social media channels and you can follow it there.
To ask a question, please click "raise hand" and this will enter you into the queue for questions. (It can be found under the tab: participants.)
Please make sure you have a microphone connected or active on your computer. Do not ask questions via the chat as we cannot guarantee that we will incorporate them into the q&a session.
The VPC will be held in English, no translation will be provided.
Note that due to the volume of questions, we are no longer able to take them from phone callers. Media contacts: mediainquiries@who.int You are receiving this NO-REPLY email because you are included on a WHO mail list.
If you have been forwarded this update you can click here to subscribe.
Journalists may send feedback to mediainquiries@who.int Share Tweet Share Forward | World Health Organization, Avenue Appia 20, 1202 Geneva 27, Switzerland Unsubscribe |
| 